BTK-IN-7

BTK-IN-7 is a highly selective and potent BTK inhibitor with a 4.0 nM IC50, demonstrating significant selectivity over ITK and EGFR. It shows robust antitumor efficacy in cellular assays and is a valuable tool for investigating B-cell receptor signaling in oncology and autoimmune disease research, both in vitro and in vivo.